Moringa Chewable Tablets (morinGO) originated from a PhD research project led by an international postgraduate student under the supervision of Prof. Ir. Dr. Yus Aniza Yusof. The innovation was officially patented (MY192867A) on 28 March 2017 and further refined with industry-grade technology for commercial scalability. On 26 August 2024, On 26 August 2024, NutraMagis Sdn Bhd (a start-up company incorporated on 18 January 2023) obtained the license from Universiti Putra Malaysia (UPM) to commercialise the Moringa Chewable Tablets.
Unlike other forms of moringa products such powders and capsules which require water during consumption, our moringa chewable tablets do not need water when consume since the tablets dissolve in the mouth during chewing
Processed thoroughly such that the moringa’s natural bitterness disappeared, leaving only with pleasant mint flavour
Does not need to mask (like certain other brands) the moringa’s natural bitterness with the addition of other herbs (such habbatus sauda, sunnah herbs etc), thus ensures control of dosage and active ingredients.
Reduce the risk of choking or aspiration that can occur with solid dosage forms, as experienced by those with difficulty in swallowing due to neurological disorders, structural blockages, or medical conditions such as GERD and cancer
Higher bioavailability via rapid nutrients absorption through the rich blood supply under the tongue and in the buccal cavity, leading to a quicker onset of action while bypassing the digestive tract or liver metabolism.